This compound is a chemical compound used as a pharmaceutical intermediate. It features a complex polycyclic structure containing nitrogen heterocycles and is supplied in dihydrochloride salt form.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2050038-84-9
8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
Research compound for medicinal chemistry
2-Amino-5-iodopyridine
Pharmaceutical intermediate
3-Amino-4-chloropyridine
Pharmaceutical intermediate for synthesis
3-(4-chlorobenzylidene)isobenzofuran-1(3H)-one
Pharmaceutical intermediate for synthesis
Isopropyl ((s)-((((r)-1-(6-amino-9h-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-d-alaninate
pharmaceutical impurity standard
Upadacitinib hemihydrate
active pharmaceutical ingredient
Upadacitinib
Janus kinase inhibitor
Upadacitinib
Janus kinase inhibitor active pharmaceutical ingredient
12-[(3R,4S)-4-ethylpyrrolidin-3-yl]-1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaene;dihydrochloride
LKVHWZCFMAQTFX-NKRBYZSKSA-N
CC[C@@H]1CNC[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3.Cl.Cl
—